Americans 'Hostages' To 'Ransom' Drug Prices, Senators Charge
This article was originally published in Scrip
Drug companies like Turing Pharmaceuticals AG and Valeant Pharmaceuticals International Inc., which have significantly raised the prices of their older, off-patent drugs, were accused on Dec. 9 by lawmakers of holding American patients hostage for ransom – a situation some members of Congress argued needs to be controlled through price regulations, like those used to rein in the railroad, electric utilities and telephone industries.
You may also be interested in...
It's uncertain whether Democratic presidential candidate Hillary Clinton's attempt at drug pricing reform would be viable, but it's one analysts say to take seriously because the first step could lead to more.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.